Advertisement

March 2, 2022

Rapid Medical Names Eitan Havis as International President

March 2, 2022—Rapid Medical, a developer of neurovascular devices based in Yokneam, Israel, announced that Eitan Havis has been named President, International. Mr. Havis will oversee the commercial expansion of the company’s advanced neurovascular technologies to treat hemorrhagic and ischemic stroke patients in Europe, Asia, and other geographies.

Mr. Havis joined Rapid Medical in 2013 as the Vice President of Sales and Marketing. During his tenure, he helped grow the company from an early stage start-up to a well-funded commercial operation. He brings 20 years of sales leadership experience for both growth-stage and large medical device companies. With Mr. Havis’s leadership, the company has launched three product franchises for neurointerventionalists.

Ronen Eckhouse, who is CEO and Cofounder of Rapid Medical, commented in the company’s press release, “Eitan has been a crucial leader in growing the company from its infancy. His leadership and professional expertise will enable us to further develop and expand our international presence.”

Mr. Havis added, “Rapid Medical’s devices provide interventionalists with enhanced control inside of the vessel, allowing them to tailor the treatment to each patient. I am continuously inspired by our talented team as we bring these advanced solutions to physicians across the globe.”

Advertisement


March 4, 2022

CSI Appoints Dr. Jeffery W. Chambers as Chief Medical Officer

March 2, 2022

Study Evaluates Incidence of and Risk Factors for IVC Thrombosis in Patients With IVC Filters


)